KD Logo

Alkermes plc [ALKS] EVP R&D, Chief Medical Officer makes an insider purchase of 14,349 shares worth 0.44 million.

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Alkermes plc shares valued at $441,550 were sold by Hopkinson Craig C. on Dec 04 ’24. At $30.77 per share, Hopkinson Craig C. sold 14,349 shares. The insider’s holdings dropped to 68,951 shares worth approximately $2.14 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Hopkinson Craig C. purchased 14,349 shares, netting a total of over 441,550 in proceeds.

Before that, Nichols Christian Todd had added 5,208 shares to its account. In a trade valued at $151,813, the Officer bought Alkermes plc shares for $29.15 each.

As published in a research note from Stifel on November 05, 2024, Alkermes plc [ALKS] has been rated up from a Hold to a Buy and the price target has been revised to $36 from $25. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of March 19, 2024, Robert W. Baird has initiated its “an Outperform” rating for ALKS. Earlier on February 20, 2024, UBS downgraded its rating. Their new recommendation was “a Sell” for ALKS stock which previously was a “a Neutral”.

Analyzing ALKS Stock Performance

During the last five days, there has been a surge of approximately 6.19%. Over the course of the year, Alkermes plc shares have jumped approximately 11.97%. Shares of the company reached a 52-week high of $32.88 on 02/16/24 and a 52-week low of $22.90 on 07/10/24. A 50-day SMA is recorded $28.11, while a 200-day SMA reached $26.61. Nevertheless, trading volume fell to 1.73 million shares from 2.03 million shares the previous day.

Support And Resistance Levels for Alkermes plc (ALKS)

According to the 24-hour chart, there is a support level at 29.88, which, if violated, would cause prices to drop to 28.70. In the upper region, resistance lies at 31.74. The next price resistance is at 32.42. RSI (Relative Strength Index) is 67.84 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.20, which suggests the price will increase in the coming days. Percent R is at 4.36%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Most Popular